G GSK

GSK Plc

DRUG MANUFACTURERS - GENERAL · HEALTHCARE

GlaxoSmithKline PLC (GSK) is a leading global biopharmaceutical company based in Brentford, UK, committed to improving health outcomes through its innovative portfolio which includes pharmaceuticals, vaccines, and consumer healthcare products. With a strong emphasis on research and development, GSK ...

$49.51

+1.71% (+$0.83)

Volume 4.47M

52W High $61.70

52W Low $45.81

Market Cap $102.06B

← Back to Calendar Compare with Others →

Next Earnings Report

Last Reported

Oct 28, 2026 Beat

Actual: $1.47 vs. Consensus: $1.40

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q3 2026 Oct 28, 2026

1-Day: -0.12%

Q2 2026 Jul 28, 2026

1-Day: -0.91%

Q1 2026 Apr 29, 2026

1-Day: +1.77%

5-Day: -0.97%

Q4 2025 Feb 4, 2026

1-Day: +3.39%

5-Day: +3.11%

Revenue & Financial Performance

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q3'26	$8.82B	+3.2%	74.5%	28.9%	$1.53B
Q2'26	$8.41B	+5.3%	73.1%	5.7%	$435.0M
Q1'26	$7.63B	+1.5%	75.4%	30.1%	$1.74B
Q4'25	$8.62B	+6.2%	69.2%	17.5%	$636.0M
Q3'25	$8.55B	+6.7%	73.6%	30.3%	$2.01B
Q2'25	$7.99B	+1.3%	72.9%	25.3%	$1.44B
Q1'25	$7.52B	+2.1%	74.2%	29.5%	$1.62B
Q4'24	$8.12B	+0.8%	68.5%	8.6%	$414.0M

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q3 2026	Oct 28, 2026	$1.40	$1.48	$1.47	+5.00%	Met
Q2 2026	Jul 28, 2026	$1.27	$1.36	$1.36	+7.09%	Met
Q1 2026	Apr 29, 2026	$1.16	$1.26	$1.26	+8.62%	Met
Q4 2025	Feb 4, 2026	$0.62	$0.70	$0.70	+12.90%	Met
Q3 2025	Oct 29, 2025	$1.26	$1.26	$1.46	+15.87%	Beat
Q2 2025	Jul 30, 2025	$1.11	$1.20	$1.24	+11.71%	Beat
Q1 2025	Apr 30, 2025	$1.04	$1.14	$1.20	+15.38%	Beat
Q4 2024	Feb 5, 2025	$0.49	$0.52	$0.58	+18.37%	Beat
Q3 2024	Oct 30, 2024	$1.16	$1.24	$1.29	+11.21%	Beat
Q2 2024	Jul 31, 2024	$0.98	$1.06	$1.11	+13.27%	Beat
Q1 2024	May 1, 2024	$0.94	$0.95	$1.08	+14.89%	Beat
Q4 2023	Jan 31, 2024	$0.77	$0.82	$0.73	-5.19%	Missed